Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: | Antabuse |
Active Ingredient: | Disulfiram 200mg |
Dosage Form: | Effervescent tablet |
New Zealand Sponsor: | Teva Pharma (New Zealand) Limited |
Manufacturer: | Recipharm Pharmaservices Pvt. Limited., Nelamangala, India |
Product: | Ezetimibe Sandoz |
Active Ingredient: | Ezetimibe 10mg |
Dosage Form: | Tablet |
New Zealand Sponsor: | Novartis New Zealand Limited |
Manufacturer: | Lek Pharmaceuticals d.d., Ljubljana, Slovenia |
Product: | Metaraminol |
Active Ingredient: | Metaraminol tartrate 0.95mg/mL equivalent to metaraminol 0.5mg/mL |
Dosage Form: | Solution for injection |
New Zealand Sponsor: | Max Health Limited |
Manufacturer: | Torbay and South Devon NHS Foundation Trust, Paignton, United Kingdom |
Product: | Metaraminol |
Active Ingredient: | Metaraminol tartrate 19mg/mL equivalent to metaraminol 10mg/mL |
Dosage Form: | Solution for injection |
New Zealand Sponsor: | Max Health Limited |
Manufacturer: | Torbay and South Devon NHS Foundation Trust, Paignton, United Kingdom |
Dated this 13th day of January 2023.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).